About Enhancer
| Enhancer ID: | E_04052 |
| Species: | Mus musculus |
| Position : | chr16:19007329-19008187   |
| Year: | 2023 |
| Title: | YY1 Binding to Regulatory Elements That Lack Enhancer Activity Promotes Locus Folding and Gene Activation. |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 37858706 |
| Tissue: | bone marrow |
| Tissue Ontology ID: | UBERON:0002371 |
| Cell Source: | 103/BCL-2 pre-B cells |
| Cell Type: | precursor B cell |
| Cell Ontology ID: | CL:0000817 |
| Experiment Type: | Enhancer activity assay; TF binding assay; enhancer-hub / locus-folding analysis |
| High Throughput Method: | ATAC-seq; ChIP-seq reanalysis |
| Low Throughput Method: | Luciferase reporter assay; ChIP-qPCR; targeted 3C |
About Target Gene
| Target gene : | Iglv1 |
About TF
| TF name : | Tcf3 |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Tcf3 | CDO in myogenesis | reactome | 29 |
| Tcf3 | ID | netpath | 38 |
| Tcf3 | Notch-mediated HES/HEY network | pid | 48 |
| Tcf3 | Notch | netpath | 76 |
| Tcf3 | p38 signaling mediated by MAPKAP kinases | pid | 21 |
| Tcf3 | Regulation of nuclear SMAD2/3 signaling | pid | 82 |
| Tcf3 | Wnt | netpath | 118 |
| Tcf3 | Hs_Ectoderm_Differentiation_WP2858_89329 | wikipathways | 56 |
Enhancer Associated Network
Overlapping Enhancers (mm10)
7 found
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00922 | chr16:19007329-19008187 | bone marrow | pro-B cell | NA |
| E_00923 | chr16:19007329-19008187 | bone marrow | pro-B cell | NA |
| E_00955 | chr16:19007329-19008187 | bone marrow | pro-B cell | NA |
| E_00956 | chr16:19007329-19008187 | bone marrow | pro-B cell | NA |
| E_04050 | chr16:19007329-19008187 | bone marrow | precursor B cell | NA |
| E_04051 | chr16:19007329-19008187 | bone marrow | precursor B cell | NA |
| E_04053 | chr16:19007329-19008187 | bone marrow | precursor B cell | NA |
Expression of Target Genes for the Enhancer